Kabon (Shenzhen) Medical Technology
Makes high quality Ankle Foot Orthosis such as Carbon AFO, Thermoplastic AFO, 3D customized AFO
About Kabon (Shenzhen) Medical Technology
Kabon (Shenzhen) Medical Technology, also known as CarbonMed, was established in Shenzhen, China, in 2018. The company concentrates on developing technologies for non-vascular interventional therapy. Its team is composed of professionals from globally recognized institutions like Drexel University and Johns Hopkins University.
The firm operates within the medical device industry, specifically focusing on diagnostic and surgical equipment. It serves surgical departments such as urology, hepatobiliary surgery, and rehabilitation by providing a complete portfolio of equipment and surgical consumables. The business model is centered on its image fusion ultrasound platform technology. In July 2023, the company secured $13.9 million in a Series A funding round, indicating it is in a revenue-generating stage.
Kabon's main offering is the VENUS system, an intelligent magnetic navigation system that utilizes multi-modal medical image fusion ultrasound. This technology addresses challenges in non-vascular interventions by improving the visualization of lesions and enhancing procedural safety. A key feature of the VENUS system is its ability to fuse pre-operative MRI/CT scans with intra-operative ultrasound images, providing real-time 3D navigation for probe and needle tracking. This allows for precise pathway planning, automatic segmentation of target organs, and real-time tracking of the needle tip. The system is designed to be user-friendly with organ-specific programs for procedures like percutaneous nephrolithotomy (PCNL) and prostate biopsies, aiming to increase the positive detection rate in biopsies and reduce surgical risks like bleeding and infection.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 13.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Hard Tech
- Technology
- 3D Technology
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2023 | $14M | $55M | Jinding Capital · Cowin Capital | ↗ |
| SEED✓Equity / VC | Aug 2022 | $2.8M | $11M | Jinding Capital · Shenzhen Zhongxiaodan | ↗ |
Growth signals
Latest recorded traffic for Kabon (Shenzhen) Medical Technology is 440 monthly website visits, down 74.1% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Kabon (Shenzhen) Medical Technology in its local ecosystem
The Kabon (Shenzhen) Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Jinding Capital- SZShenzhen Zhongxiaodan
Series A1 investor entered at this stage
Cowin Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kabon (Shenzhen) Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kabon (Shenzhen) Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









